vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and ONESPAWORLD HOLDINGS Ltd (OSW). Click either name above to swap in a different company.
ONESPAWORLD HOLDINGS Ltd is the larger business by last-quarter revenue ($242.1M vs $185.2M, roughly 1.3× AMICUS THERAPEUTICS, INC.). ONESPAWORLD HOLDINGS Ltd runs the higher net margin — 5.0% vs 0.9%, a 4.1% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs 11.5%). AMICUS THERAPEUTICS, INC. produced more free cash flow last quarter ($16.0M vs $14.9M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 7.1%).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
FOLD vs OSW — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $185.2M | $242.1M |
| Net Profit | $1.7M | $12.1M |
| Gross Margin | 85.7% | — |
| Operating Margin | 8.6% | 6.8% |
| Net Margin | 0.9% | 5.0% |
| Revenue YoY | 23.7% | 11.5% |
| Net Profit YoY | -88.5% | -16.2% |
| EPS (diluted) | $0.00 | $0.12 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $185.2M | $242.1M | ||
| Q3 25 | $169.1M | $258.5M | ||
| Q2 25 | $154.7M | $240.7M | ||
| Q1 25 | $125.2M | $219.6M | ||
| Q4 24 | $149.7M | $217.2M | ||
| Q3 24 | $141.5M | $241.7M | ||
| Q2 24 | $126.7M | $224.9M | ||
| Q1 24 | $110.4M | $211.2M |
| Q4 25 | $1.7M | $12.1M | ||
| Q3 25 | $17.3M | $24.3M | ||
| Q2 25 | $-24.4M | $19.9M | ||
| Q1 25 | $-21.7M | $15.3M | ||
| Q4 24 | $14.7M | $14.4M | ||
| Q3 24 | $-6.7M | $21.6M | ||
| Q2 24 | $-15.7M | $15.8M | ||
| Q1 24 | $-48.4M | $21.2M |
| Q4 25 | 85.7% | — | ||
| Q3 25 | 88.5% | — | ||
| Q2 25 | 90.2% | — | ||
| Q1 25 | 90.7% | — | ||
| Q4 24 | 90.1% | — | ||
| Q3 24 | 90.6% | — | ||
| Q2 24 | 91.1% | — | ||
| Q1 24 | 87.7% | — |
| Q4 25 | 8.6% | 6.8% | ||
| Q3 25 | 20.3% | 10.2% | ||
| Q2 25 | -6.1% | 9.2% | ||
| Q1 25 | -6.3% | 7.7% | ||
| Q4 24 | 10.7% | 7.9% | ||
| Q3 24 | 15.3% | 10.3% | ||
| Q2 24 | 11.8% | 8.4% | ||
| Q1 24 | -25.1% | 8.0% |
| Q4 25 | 0.9% | 5.0% | ||
| Q3 25 | 10.2% | 9.4% | ||
| Q2 25 | -15.8% | 8.3% | ||
| Q1 25 | -17.3% | 7.0% | ||
| Q4 24 | 9.8% | 6.6% | ||
| Q3 24 | -4.8% | 8.9% | ||
| Q2 24 | -12.4% | 7.0% | ||
| Q1 24 | -43.9% | 10.0% |
| Q4 25 | $0.00 | $0.12 | ||
| Q3 25 | $0.06 | $0.23 | ||
| Q2 25 | $-0.08 | $0.19 | ||
| Q1 25 | $-0.07 | $0.15 | ||
| Q4 24 | $0.05 | $0.13 | ||
| Q3 24 | $-0.02 | $0.20 | ||
| Q2 24 | $-0.05 | $0.15 | ||
| Q1 24 | $-0.16 | $0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | $16.3M |
| Total DebtLower is stronger | $392.7M | $84.0M |
| Stockholders' EquityBook value | $274.2M | $542.6M |
| Total Assets | $949.9M | $707.1M |
| Debt / EquityLower = less leverage | 1.43× | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $293.5M | $16.3M | ||
| Q3 25 | $263.8M | $29.6M | ||
| Q2 25 | $231.0M | $35.0M | ||
| Q1 25 | $250.6M | $22.6M | ||
| Q4 24 | $249.9M | $57.4M | ||
| Q3 24 | $249.8M | $48.8M | ||
| Q2 24 | $260.1M | $62.5M | ||
| Q1 24 | $239.6M | $65.4M |
| Q4 25 | $392.7M | $84.0M | ||
| Q3 25 | $392.0M | $85.2M | ||
| Q2 25 | $391.3M | $96.2M | ||
| Q1 25 | $390.7M | $97.4M | ||
| Q4 24 | $390.1M | $98.6M | ||
| Q3 24 | $389.5M | $98.7M | ||
| Q2 24 | $388.9M | $123.8M | ||
| Q1 24 | $388.4M | $138.6M |
| Q4 25 | $274.2M | $542.6M | ||
| Q3 25 | $230.4M | $552.8M | ||
| Q2 25 | $204.3M | $548.3M | ||
| Q1 25 | $193.6M | $530.6M | ||
| Q4 24 | $194.0M | $554.5M | ||
| Q3 24 | $178.8M | $540.1M | ||
| Q2 24 | $132.5M | $532.7M | ||
| Q1 24 | $130.7M | $515.5M |
| Q4 25 | $949.9M | $707.1M | ||
| Q3 25 | $868.8M | $732.6M | ||
| Q2 25 | $815.3M | $731.8M | ||
| Q1 25 | $789.8M | $708.7M | ||
| Q4 24 | $785.0M | $746.4M | ||
| Q3 24 | $786.6M | $734.0M | ||
| Q2 24 | $749.5M | $756.8M | ||
| Q1 24 | $721.8M | $763.6M |
| Q4 25 | 1.43× | 0.15× | ||
| Q3 25 | 1.70× | 0.15× | ||
| Q2 25 | 1.92× | 0.18× | ||
| Q1 25 | 2.02× | 0.18× | ||
| Q4 24 | 2.01× | 0.18× | ||
| Q3 24 | 2.18× | 0.18× | ||
| Q2 24 | 2.93× | 0.23× | ||
| Q1 24 | 2.97× | 0.27× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | $20.0M |
| Free Cash FlowOCF − Capex | $16.0M | $14.9M |
| FCF MarginFCF / Revenue | 8.6% | 6.2% |
| Capex IntensityCapex / Revenue | 0.2% | 2.1% |
| Cash ConversionOCF / Net Profit | 9.62× | 1.65× |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | $68.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $16.3M | $20.0M | ||
| Q3 25 | $35.7M | $33.2M | ||
| Q2 25 | $-26.5M | $20.3M | ||
| Q1 25 | $7.8M | $10.1M | ||
| Q4 24 | $-3.9M | $16.6M | ||
| Q3 24 | $-23.0M | $28.6M | ||
| Q2 24 | $22.7M | $18.7M | ||
| Q1 24 | $-29.7M | $15.0M |
| Q4 25 | $16.0M | $14.9M | ||
| Q3 25 | $35.3M | $27.6M | ||
| Q2 25 | $-28.9M | $17.6M | ||
| Q1 25 | $7.5M | $8.4M | ||
| Q4 24 | $-4.2M | $13.2M | ||
| Q3 24 | $-23.3M | $27.5M | ||
| Q2 24 | $21.6M | $17.6M | ||
| Q1 24 | $-31.5M | $13.7M |
| Q4 25 | 8.6% | 6.2% | ||
| Q3 25 | 20.9% | 10.7% | ||
| Q2 25 | -18.7% | 7.3% | ||
| Q1 25 | 6.0% | 3.8% | ||
| Q4 24 | -2.8% | 6.1% | ||
| Q3 24 | -16.5% | 11.4% | ||
| Q2 24 | 17.0% | 7.8% | ||
| Q1 24 | -28.5% | 6.5% |
| Q4 25 | 0.2% | 2.1% | ||
| Q3 25 | 0.2% | 2.2% | ||
| Q2 25 | 1.6% | 1.1% | ||
| Q1 25 | 0.2% | 0.8% | ||
| Q4 24 | 0.2% | 1.5% | ||
| Q3 24 | 0.3% | 0.5% | ||
| Q2 24 | 0.9% | 0.5% | ||
| Q1 24 | 1.6% | 0.6% |
| Q4 25 | 9.62× | 1.65× | ||
| Q3 25 | 2.06× | 1.36× | ||
| Q2 25 | — | 1.02× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | -0.27× | 1.15× | ||
| Q3 24 | — | 1.33× | ||
| Q2 24 | — | 1.19× | ||
| Q1 24 | — | 0.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
OSW
| Services | $197.3M | 82% |
| Products | $44.8M | 18% |
